DS

Dheeraj Sharma

Director Director DIN 09660944
DIN 09660944 First appointment Jul 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2022
Shareholding value Locked Premium profile

About Dheeraj Sharma

Data last updated:

Dheeraj Sharma has 4 years in corporate governance. Formerly with 1 company, such as Genexa Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09660944
Primary Designation Director
First Appointment 04 Jul 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Genexa Drugs Private Limited U24290DL2022PTC401129
Director04 Jul 20222022Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Genexa Drugs Private Limited
Premium access

Shareholding and investment profile for Dheeraj Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dheeraj Sharma

Dheeraj Sharma has 4 years in corporate governance. Formerly with 1 company, such as Genexa Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

Dheeraj Sharma is associated with 0 companies as a director.

Dheeraj Sharma has expertise in General Business.

Dheeraj Sharma has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available